Eli Lilly and Co (NYSE:LLY)
| 139.50 Delayed Data As of Apr 03 |  -2.68 / -1.88%Today’s Change | 101.36 Today|||52-Week Range 147.87 | +6.14% Year-to-Date |
Latest LLY News | Press Releases
| Pfizer, Merck, and Eli Lilly Will Pay Their Doctors to Get Back to Treating Patients During the COVID-19 Pandemic Apr 02 / MotleyFool.com - Paid Partner Content | Better Buy: Geron vs. Acceleron Mar 27 / MotleyFool.com - Paid Partner Content |
| Do Clinical Trial Delays Mean Trouble for Pharmaceutical Stocks? Apr 01 / MotleyFool.com - Paid Partner Content | 3 Reasons Pharma Stocks Are a Buy Right Now Mar 25 / MotleyFool.com - Paid Partner Content |
| Eli Lilly Licenses Immunology Drugs for Up to $880 Million Mar 31 / MotleyFool.com - Paid Partner Content | Eli Lilly to Pause Enrollment in Most Drug Trials Mar 23 / MotleyFool.com - Paid Partner Content |
| Is Pfizer a Great Stock to Buy During the Coronavirus Market Crash? Mar 31 / MotleyFool.com - Paid Partner Content | Eli Lilly Will Provide Drive-Through Coronavirus Testing to Indianapolis Healthcare Workers Mar 22 / MotleyFool.com - Paid Partner Content |
